Tag: sponsor SAE responsibilities

Global Reporting Timelines for Serious Adverse Events in Clinical Trials

September 5, 2025

Global Reporting Timelines for Serious Adverse Events in Clinical Trials Understanding Global Reporting Timelines for SAEs in Clinical Trials Why Reporting Timelines Matter in Pharmacovigilance In clinical research, reporting Serious Adverse Events (SAEs) within regulatory timelines is one of the most critical obligations under Good Clinical Practice (GCP). These timelines exist to ensure that regulators…

Adverse Event Reporting and Management, Expedited Reporting Timelines

Sponsor Obligations for Global SAE Management in Clinical Trials

July 3, 2025

digi

Sponsor Obligations for Global SAE Management in Clinical Trials Comprehensive Guide to Sponsor Obligations for Global SAE Management Managing Serious Adverse Events (SAEs) across multinational clinical trials is a core responsibility of trial sponsors. Regulatory bodies such as the USFDA, EMA, and CDSCO place immense accountability on sponsors to ensure timely, accurate, and consistent reporting…

Safety Reporting and Pharmacovigilance, Serious Adverse Event (SAE) Management

SAE Reporting Timelines and Responsibilities Under CDSCO Guidelines

May 13, 2025

digi

SAE Reporting Timelines and Responsibilities Under CDSCO Guidelines Understanding SAE Reporting Timelines and Responsibilities in India Under CDSCO Serious Adverse Event (SAE) reporting is a cornerstone of clinical trial safety management. In India, the Central Drugs Standard Control Organization (CDSCO) enforces specific timelines and responsibilities for sponsors, investigators, and ethics committees (ECs) to ensure swift…

CDSCO (India) Guidelines, Regulatory Guidelines